Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
2.83 Up 0.04(1.43%) Apr 17, 4:00PM EDT
|After Hours : 2.83 0.00 (0.00%) Apr 17, 4:29PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development10,107  11,341  16,569  8,719  
Selling General and Administrative3,388  2,734  3,545  3,074  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (13,495) (14,075) (20,114) (11,793)
Income from Continuing Operations
Total Other Income/Expenses Net153  166  186  77  
Earnings Before Interest And Taxes(13,342)(13,909)(19,928)(11,716)
Interest Expense8  10  12  22  
Income Before Tax(13,350)(13,919)(19,940)(11,738)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(13,350)(13,919)(19,940)(11,738)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (13,350) (13,919) (19,940) (11,738)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (13,350) (13,919) (19,940) (11,738)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.